Literature DB >> 7707522

The N-terminal region of the adenovirus type 5 E1A proteins can repress expression of cellular genes via two distinct but overlapping domains.

J C Dorsman1, B M Hagmeyer, J Veenstra, P Elfferich, N Nabben, A Zantema, A J van der Eb.   

Abstract

The transforming E1A 12S and E1A 13S proteins of human adenovirus type 5 (Ad5) contain two and three conserved regions, respectively. In the present study, the contribution of sequences in the nonconserved N-terminal region of the E1A proteins to morphological transformation and to down-regulation of a number of mitogen-inducible genes was investigated. As described previously, transformation of NRK cells (an established normal rat kidney cell line) results in denser cell growth and a cuboidal cellular morphology. None of the cells expressing N-terminally mutated E1A proteins, however, show these transformed properties, which suggests an important role for sequences in that domain. The decrease in cyclin D1 levels requires exactly the same sequences. The ability to transform NRK cells and to reduce cyclin D1 levels does not correlate with the presence in the E1A proteins of binding domains for p300, CBP, p107, pRb, cyclin A, or cdk2. In contrast, down-regulation of expression of the JE gene in NRK cells and repression of transcription of the collagenase gene in human HeLa cells does correlate with the presence in the E1A proteins of an intact binding domain for p300 and CBP. The results suggest that the N-terminal domain of the E1A proteins can repress expression of cellular genes by at least two different mechanisms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7707522      PMCID: PMC188995     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5'-flanking region.

Authors:  P Angel; I Baumann; B Stein; H Delius; H J Rahmsdorf; P Herrlich
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

3.  Immortalization by c-myc, H-ras, and Ela oncogenes induces differential cellular gene expression and growth factor responses.

Authors:  A Kelekar; M D Cole
Journal:  Mol Cell Biol       Date:  1987-11       Impact factor: 4.272

4.  Morphological transformation of established rodent cell lines by high-level expression of the adenovirus type 2 E1a gene.

Authors:  A W Senear; J B Lewis
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

5.  The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1.

Authors:  P Angel; K Hattori; T Smeal; M Karin
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

6.  Use of deletion and point mutants spanning the coding region of the adenovirus 5 E1A gene to define a domain that is essential for transcriptional activation.

Authors:  T N Jelsma; J A Howe; C M Evelegh; N F Cunniff; M H Skiadopoulos; M R Floroff; J E Denman; S T Bayley
Journal:  Virology       Date:  1988-04       Impact factor: 3.616

7.  E1A oncogene expression level in sarcoma cells: an independent determinant of cytolytic susceptibility and tumor rejection.

Authors:  J L Cook; B A Wilson; L A Wolf; T A Walker
Journal:  Oncogene       Date:  1993-03       Impact factor: 9.867

8.  E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators.

Authors:  Z Arany; W R Sellers; D M Livingston; R Eckner
Journal:  Cell       Date:  1994-06-17       Impact factor: 41.582

9.  Pentapeptide nuclear localization signal in adenovirus E1a.

Authors:  R H Lyons; B Q Ferguson; M Rosenberg
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

10.  Mutational analysis of the adenovirus E1a gene: the role of transcriptional regulation in transformation.

Authors:  J F Schneider; F Fisher; C R Goding; N C Jones
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

View more
  9 in total

1.  A specific lysine in c-Jun is required for transcriptional repression by E1A and is acetylated by p300.

Authors:  R G Vries; M Prudenziati; C Zwartjes; M Verlaan; E Kalkhoven; A Zantema
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

2.  A novel E1A domain mediates skeletal-muscle-specific enhancer repression independently of pRB and p300 binding.

Authors:  A Sandmöller; H Meents; H H Arnold
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

3.  Adenovirus E1A downregulates cJun- and JunB-mediated transcription by targeting their coactivator p300.

Authors:  J S Lee; R H See; T Deng; Y Shi
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

4.  Repression of cyclin D1 expression does not contribute to initiation or maintenance of cell transformation by adenovirus type 5 E1.

Authors:  O Kranenburg; P Keblusek; A J Van der Eb; A Zantema
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Role of p300-family proteins in E1A oncogene induction of cytolytic susceptibility and tumor cell rejection.

Authors:  J L Cook; C K Krantz; B A Routes
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

6.  Identification of specific amino acid residues of adenovirus 12 E1A involved in transformation and p300 binding.

Authors:  Y Sawada; M Ishino; K Miura; E Ohtsuka; K Fujinaga
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

7.  Induction of susceptibility to tumor necrosis factor by E1A is dependent on binding to either p300 or p105-Rb and induction of DNA synthesis.

Authors:  J Shisler; P Duerksen-Hughes; T M Hermiston; W S Wold; L R Gooding
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

8.  A novel function of adenovirus E1A is required to overcome growth arrest by the CDK2 inhibitor p27(Kip1).

Authors:  K Alevizopoulos; B Catarin; J Vlach; B Amati
Journal:  EMBO J       Date:  1998-10-15       Impact factor: 11.598

9.  A cancer-specific transcriptional signature in human neoplasia.

Authors:  Francesco Nicassio; Fabrizio Bianchi; Maria Capra; Manuela Vecchi; Stefano Confalonieri; Marco Bianchi; Deborah Pajalunga; Marco Crescenzi; Ian Marc Bonapace; Pier Paolo Di Fiore
Journal:  J Clin Invest       Date:  2005-10-13       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.